Your browser doesn't support javascript.
loading
Developing a robust in vitro release method for a polymeric nanoparticle: Challenges and learnings.
Mead, Heather; Paraskevopoulou, Vasiliki; Smith, Natalie; Gibson, Rhiannon; Amerio-Cox, Marius; Taylor-Vine, Georgia; Armstrong, Thomas; Harris, Kate; Wren, Stephen; Mann, James.
Affiliation
  • Mead H; New Modalities & Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK. Electronic address: Heather.mead@astrazeneca.com.
  • Paraskevopoulou V; New Modalities & Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK.
  • Smith N; New Modalities & Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK.
  • Gibson R; New Modalities & Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK.
  • Amerio-Cox M; New Modalities & Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK.
  • Taylor-Vine G; New Modalities & Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK.
  • Armstrong T; New Modalities & Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK.
  • Harris K; New Modalities & Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK.
  • Wren S; New Modalities & Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK.
  • Mann J; Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK.
Int J Pharm ; 644: 123317, 2023 Sep 25.
Article de En | MEDLINE | ID: mdl-37586575

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Chimie pharmaceutique / Nanoparticules Type d'étude: Guideline Limites: Humans Langue: En Journal: Int J Pharm Année: 2023 Type de document: Article Pays de publication: Pays-Bas

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Chimie pharmaceutique / Nanoparticules Type d'étude: Guideline Limites: Humans Langue: En Journal: Int J Pharm Année: 2023 Type de document: Article Pays de publication: Pays-Bas